GLP1R and eating disorder: Finally, the hypothesis of GLP-1 analogs as a trigger of restrictive eating disorders is not well established in the literature and needs further verification in long-term studies that should be more holistic and concentrate not only on the physiological effects of GLP-1 RAs therapy such as anthropometric measurements but also on the psychological impact they have on patients.